AP2157A - 2-substituted pyrimidines. - Google Patents

2-substituted pyrimidines.

Info

Publication number
AP2157A
AP2157A AP2006003497A AP2006003497A AP2157A AP 2157 A AP2157 A AP 2157A AP 2006003497 A AP2006003497 A AP 2006003497A AP 2006003497 A AP2006003497 A AP 2006003497A AP 2157 A AP2157 A AP 2157A
Authority
AP
ARIPO
Prior art keywords
substituted pyrimidines
pyrimidines
substituted
Prior art date
Application number
AP2006003497A
Other languages
English (en)
Other versions
AP2006003497A0 (en
Inventor
Anja Dr Schwogler
Markus Dr Gewehr
Bernd Dr Mueller
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of AP2006003497A0 publication Critical patent/AP2006003497A0/xx
Application granted granted Critical
Publication of AP2157A publication Critical patent/AP2157A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AP2006003497A 2003-07-24 2004-07-15 2-substituted pyrimidines. AP2157A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10333857 2003-07-24
DE10357714 2003-12-09
PCT/EP2004/007877 WO2005012261A1 (de) 2003-07-24 2004-07-15 2-substituierte pyrimidine

Publications (2)

Publication Number Publication Date
AP2006003497A0 AP2006003497A0 (en) 2006-02-28
AP2157A true AP2157A (en) 2010-09-13

Family

ID=34117367

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2006003497A AP2157A (en) 2003-07-24 2004-07-15 2-substituted pyrimidines.

Country Status (30)

Country Link
US (1) US7375108B2 (da)
EP (1) EP1651618B1 (da)
JP (1) JP2006528603A (da)
KR (1) KR20060052857A (da)
AP (1) AP2157A (da)
AR (1) AR045100A1 (da)
AT (1) ATE350370T1 (da)
AU (1) AU2004261373B8 (da)
BR (1) BRPI0412891A (da)
CA (1) CA2532718A1 (da)
CO (1) CO5660292A2 (da)
CR (1) CR8184A (da)
CY (1) CY1106391T1 (da)
DE (1) DE502004002570D1 (da)
DK (1) DK1651618T3 (da)
EA (1) EA010566B1 (da)
EC (1) ECSP066278A (da)
ES (1) ES2279395T3 (da)
HR (1) HRP20070057T3 (da)
IL (1) IL172848A0 (da)
MA (1) MA27949A1 (da)
MX (1) MXPA06000038A (da)
NZ (1) NZ545103A (da)
PE (1) PE20050882A1 (da)
PL (1) PL1651618T3 (da)
PT (1) PT1651618E (da)
SI (1) SI1651618T1 (da)
TW (1) TW200516075A (da)
UY (1) UY28436A1 (da)
WO (1) WO2005012261A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080132522A1 (en) * 2004-07-14 2008-06-05 Basf Aktiengesellschaft 2-Substituted Pyrimidines, Method for Their Production and Their Use for Controlling Pathogenic Fungi
CL2007002231A1 (es) * 2006-08-02 2008-04-11 Basf Ag Uso de compuestos derivados de 5-(het) arilpirimidina para combatir hongos daninos; compuestos derivados de 5-(het) arilpirimidina; agente fungicida; y agente farmaceutico.
JP6041808B2 (ja) * 2010-11-16 2016-12-14 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 蛋白質脱アセチル化酵素抑制剤としてのピリミジン水酸基アミド化合物およびその利用方法
US9403779B2 (en) 2013-10-08 2016-08-02 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors
EP3055299B1 (en) 2013-10-10 2021-01-06 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
JP2016534069A (ja) 2013-10-24 2016-11-04 メイヨ・ファウンデーション・フォー・メディカル・エデュケーション・アンド・リサーチ Hdac6阻害剤での多嚢胞性疾患の治療
US9949972B2 (en) 2013-12-03 2018-04-24 Acetylon Pharmaceuticals, Inc Combinations of histone deacetylase inhibitors and immunomodulatory drugs
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
EP3166603B1 (en) 2014-07-07 2020-02-12 Acetylon Pharmaceuticals, Inc. Treatment of leukemia with histone deacetylase inhibitors
CA2969790A1 (en) 2014-12-05 2016-06-09 University of Modena and Reggio Emilia Combinations of histone deacetylase inhibitors and bendamustine
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
JP2019515909A (ja) 2016-04-19 2019-06-13 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 慢性リンパ性白血病の治療を目的とするhdac阻害剤単独またはbtk阻害剤との配合物
US20210369664A1 (en) * 2016-07-20 2021-12-02 Tohoku University Prophylactic or therapeutic agent for pulmonary hypertension which comprises ppar? agonist

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074753A2 (de) * 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen
WO2003043993A1 (de) * 2001-11-19 2003-05-30 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2412010A1 (en) 2000-06-13 2001-12-20 Basf Aktiengesellschaft Fungicidal 5-phenyl substituted 2-(cyanoamino) pyrimidines

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002074753A2 (de) * 2001-03-15 2002-09-26 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von schadpilzen
WO2003043993A1 (de) * 2001-11-19 2003-05-30 Basf Aktiengesellschaft 5-phenylpyrimidine, verfahren zu ihrer herstellung, sie enthaltende mittel und ihre verwendung

Also Published As

Publication number Publication date
UY28436A1 (es) 2005-02-28
PE20050882A1 (es) 2005-12-01
AP2006003497A0 (en) 2006-02-28
PT1651618E (pt) 2007-03-30
US7375108B2 (en) 2008-05-20
BRPI0412891A (pt) 2006-10-03
NZ545103A (en) 2008-06-30
US20070105873A1 (en) 2007-05-10
SI1651618T1 (sl) 2007-06-30
MXPA06000038A (es) 2006-03-21
WO2005012261A1 (de) 2005-02-10
KR20060052857A (ko) 2006-05-19
AU2004261373B8 (en) 2010-11-04
DE502004002570D1 (de) 2007-02-15
CY1106391T1 (el) 2011-10-12
EP1651618B1 (de) 2007-01-03
TW200516075A (en) 2005-05-16
IL172848A0 (en) 2006-06-11
HRP20070057T3 (hr) 2007-07-31
CR8184A (es) 2006-10-06
AR045100A1 (es) 2005-10-12
CO5660292A2 (es) 2006-07-31
AU2004261373B2 (en) 2010-08-19
EA010566B1 (ru) 2008-10-30
ES2279395T3 (es) 2007-08-16
MA27949A1 (fr) 2006-06-01
AU2004261373A1 (en) 2005-02-10
JP2006528603A (ja) 2006-12-21
DK1651618T3 (da) 2007-05-14
EA200600212A1 (ru) 2006-08-25
EP1651618A1 (de) 2006-05-03
ATE350370T1 (de) 2007-01-15
ECSP066278A (es) 2006-07-28
CA2532718A1 (en) 2005-02-10
PL1651618T3 (pl) 2007-05-31

Similar Documents

Publication Publication Date Title
AP2005003403A0 (en) Substituted pyrimidinones.
EG24843A (en) Herbicidal pyrimidines
EG25273A (en) Substituted dihydroquinazolines.
ZA200705040B (en) 2,4 (4,6) pyrimidine derivatives
AP2204A (en) 4-phenylamino-quinazolin-6-yl-amides.
MX267068B (es) Derivados simetricos de triazina.
ZA200400386B (en) Attachment element.
AP2157A (en) 2-substituted pyrimidines.
ZA200409550B (en) Glasses.
ZA200407840B (en) Shower assembly.
AP2006003496A0 (en) 2-Substituted pyrimidines.
IL169318A0 (en) Pyrimidines, methods for the production thereof, and use thereof
LU91022B1 (en) Sektionaltor.
GB0315045D0 (en) Dual.L
PL114818U1 (en) V .03
TJ391B (en) Medicinal-preventive biopreparation subtilben.
GB0414904D0 (en) V.s.
GB0415035D0 (en) C.s.v.
GB0315839D0 (en) www.wereuthe1.com
GB0405594D0 (en) E.v.o.
ZA200402256B (en) Down-the-hole-drill assembly.
ZA200400549B (en) Geyser.
GB0307972D0 (en) E.b.o.e.s.s
ZA200308621B (en) Construction element.
GB0310855D0 (en) B.p.w.l